Intrathecal baclofen pump implantation for complex regional pain syndrome in a patient with a spinal cord stimulator: consideration about optimal location of intrathecal catheter tip: A case report.
10.17085/apm.2018.13.2.201
- Author:
Myoung Jin KO
1
;
Hyun Seong LEE
;
Hyunji JO
;
Seong Rok KIM
;
Sangyoon JEON
;
Sang Eun LEE
Author Information
1. Department of Anesthesiology and Pain Medicine, Inje University Haeundae Paik Hospital, Busan, Korea. anelse@naver.com
- Publication Type:Case Report
- Keywords:
Baclofen;
Complex regional pain syndrome;
Intrathecal pump;
Spinal cord stimulation
- MeSH:
Ankle;
Baclofen*;
Catheters*;
Dystonia;
Female;
Follow-Up Studies;
Foot;
Humans;
Middle Aged;
Morphine;
Pain, Intractable;
Paresthesia;
Patient Satisfaction;
Spinal Cord Stimulation;
Spinal Cord*
- From:Anesthesia and Pain Medicine
2018;13(2):201-206
- CountryRepublic of Korea
- Language:English
-
Abstract:
Intrathecal baclofen (ITB) pump implantation can be used to control dystonia and severe pain associated with complex regional pain syndrome (CRPS) with or without a spinal cord stimulator (SCS). A 45-year-old female patient had gotten an SCS to control the pain of CRPS. However, she suffered from chronic intractable pain in her left ankle and foot despite paresthesia in the entire painful area because the effectiveness of the SCS gradually diminished over time. In a trial of intrathecal drug administration, baclofen was superior to morphine for pain relief, had fewer side effects, and was superior in terms of patient satisfaction. To achieve the greatest degree of pain relief from the ITB pump, the tip of the intrathecal catheter was carefully placed in relation to the SCS. Over a one-year follow-up period, the patient experienced mild pain without any adverse effects.
